welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
A Registered Cohort Study on Duchenne Muscular Dystrophy
study id #: NCT04012671
condition: Duchenne Muscular Dystrophy
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
last updated: July 19, 2019
start date: July 2019
estimated completion: December 31, 2039
phase of development: N/A
size / enrollment: 2000
- Age at death [ Time Frame: 20 years ]
The time when patient die
• Beyond 2 years old
• Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
• Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
• Presence of other clinically significant illness
other Duchenne content
U.S. appeals court upholds MIT, Harvard patents on CRISPR gene editingA U.S. appeals court on Monday allowed a...
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular DystrophyThe expanded access program will provide...
Nancy L. Kuntz, MDDr. Nancy Kuntz is Professor of pediatri...
FDA and NIH to loosen oversight of gene therapy developmentCiting the need to safely expedite the d...
UT researcher, with CureDuchenne support, launches company to treat DMD using CRISPR/Cas9 technologyEric Olson, a molecular biologist, has s...
Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophiesDuchenne and Becker muscular dystrophies...
General Rules of Stretching for Those with DuchennePerforming a daily stretching routine is...